Aeroallergens in atopic dermatitis and chronic urticaria

AC Chong, WJ Chwa, PY Ong - Current Allergy and Asthma Reports, 2022 - Springer
Abstract Purpose of Review While aeroallergens are a well-established trigger of asthma
and allergic rhinitis, their role in allergic skin diseases such as atopic dermatitis and chronic …

[HTML][HTML] Challenges in the pharmacotherapeutic management of pediatric asthma

I Ioniuc, I Miron, VV Lupu, IM Starcea, A Azoicai… - Pharmaceuticals, 2022 - mdpi.com
Bronchial asthma is one of the most common chronic conditions in pediatric practice, with
increasing prevalence hampered by poor socioeconomic impacts, leading to major public …

TH17 cells and corticosteroid insensitivity in severe asthma

Y Xie, PW Abel, TB Casale, Y Tu - Journal of Allergy and Clinical …, 2022 - Elsevier
Asthma is classically described as having either a type 2 (T2) eosinophilic phenotype or a
non-T2 neutrophilic phenotype. T2 asthma usually responds to classical bronchodilation …

Wheeze trajectories: Determinants and outcomes in the CHILD Cohort Study

R Dai, K Miliku, S Gaddipati, J Choi… - Journal of Allergy and …, 2022 - Elsevier
Background Wheezing in early life is associated with asthma in adulthood; however, the
determinants of wheezing trajectories and their associations with asthma and lung function …

The impact of patient self-monitoring via electronic medication monitor and mobile app plus remote clinician feedback on adherence to inhaled corticosteroids: a …

GS Mosnaim, DA Stempel, C Gonzalez… - The Journal of Allergy …, 2021 - Elsevier
Background Poor adherence to inhaled corticosteroids (ICSs) and overuse of short-acting
beta 2-agonists (SABAs) are associated with increased asthma morbidity. Objective To …

The prevalence of subtypes of type 2 inflammation in an unselected population of patients with severe asthma

L Frøssing, A Silberbrandt, A Von Bülow… - The Journal of Allergy …, 2021 - Elsevier
Background With the introduction of different targeted therapies for type 2 (T2)-high asthma,
there is an urgent need for markers to guide the choice of treatment. T2-high asthma …

[HTML][HTML] T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis

M Oriano, A Gramegna, F Amati, A D'Adda, M Gaffuri… - Biomedicines, 2021 - mdpi.com
Although bronchiectasis pathophysiology has been historically understood around the
presence of airway neutrophilic inflammation, recent experiences are consistent with the …

Pragmatic clinical perspective on biologics for severe refractory type 2 asthma

R Chan, CRW Kuo, B Lipworth - The Journal of Allergy and Clinical …, 2020 - Elsevier
Patients with severe refractory asthma present a challenging clinical conundrum for
practicing clinicians. Biologics that target key mediators in the type 2 inflammation cascade …

Blood eosinophils for prediction of exacerbation in preschool children with recurrent wheezing

AM Fitzpatrick, JR Grunwell, KA Cottrill, AD Mutic… - The Journal of Allergy …, 2023 - Elsevier
Background Although clinical features of type 2 inflammation have been associated with
poorer longitudinal outcomes in preschool children with recurrent wheezing, it remains …

Airway smooth muscle in contractility and remodeling of asthma: potential drug target mechanisms

L Khalfaoui, CM Pabelick - Expert opinion on therapeutic targets, 2023 - Taylor & Francis
Introduction Asthma is characterized by enhanced airway contractility and remodeling where
airway smooth muscle (ASM) plays a key role, modulated by inflammation. Understanding …